Toxin inactivation and antigen stabilization: two different uses of formaldehyde

This publication has 9 references indexed in Scilit:

• Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children
  The Journal of Pediatrics, 1993
• Acellular Pertussis Vaccines—A Solution to the Pertussis Problem?
  The Journal of Infectious Diseases, 1993
• Progress towards the development of new vaccines against whooping cough
  Vaccine, 1992
• Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: Safety and immunogenicity in 12- to 24- and 2- to 4-month-old children
  The Journal of Pediatrics, 1992
• Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.
  The Journal of Experimental Medicine, 1990
• Comparison of the detoxification courses of the histamine-sensitizing, lymphocytosis-promoting and CHO cell-clustering activities in the process of the production of acellular pertussis vaccine
  Biologicals, 1990
• Mutants of Pertussis Toxin Suitable for Vaccine Development
  Science, 1989
• Mapping of a Protective Epitope of Pertussis Toxin by In Vitro Refolding of Recombinant Fragments
  Nature Biotechnology, 1988
• DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPAN
  The Lancet, 1984